GlassScriptPhysician profile
George Alan Yesenosky
NPI 1265408470
$74,341.58
in general payments reported to CMS, 2019-2025
36 companies · $1,949 in 2025
The $1,949 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $13K · 2021: $7,564 · 2022: $18K · 2023: $15K · 2024: $4,713 · 2025: $1,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $10K · Food and Beverage: $6,532 · Consulting Fee: $3,000 · Travel and Lodging: $2,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,200.00 |
| Food and Beverage | $6,532.21 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $2,033.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $32,169.58 | 2020-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $24,521.81 | 2019-2025 | Watchman Access System, Watchman Flx, General - Therapies |
| Abbott Laboratories | $5,261.49 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,579.91 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $2,033.95 | 2019 | |
| Medtronic, INC. | $1,886.30 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Cobalt Dr Mri Surescan |
| Atricure, INC. | $1,081.43 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $598.15 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $501.90 | 2021-2025 | |
| Amgen INC. | $458.13 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $394.52 | 2019-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.97 | 2019-2025 | Jardiance |
| Pfizer INC. | $305.58 | 2019-2025 | |
| Biotronik INC. | $287.22 | 2023-2025 | Biomonitor, Amvia Edge |
| Janssen Pharmaceuticals, INC | $257.14 | 2022-2024 | Xarelto |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $222.77 | 2021-2025 | Verquvo, Steglatro |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $191.38 | 2023-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $167.69 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Abiomed | $130.24 | 2023 | Impella |
| Alnylam Pharmaceuticals INC. | $100.41 | 2025 | Onpattro |
| Philips North America LLC | $80.95 | 2019 | |
| Medicomp INC | $77.37 | 2025 | Telepatch Cardiac Monitor |
| Esperion Therapeutics, INC. | $77.11 | 2021-2024 | Nexletol |
| Daiichi Sankyo INC. | $73.16 | 2019-2022 | |
| Biosense Webster, INC. | $67.93 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Lexicon Pharmaceuticals, INC. | $56.27 | 2023 | Inpefa |
| Althera Pharmaceuticals LLC | $43.60 | 2021 | |
| Cardiva Medical, INC. | $32.46 | 2021 | |
| Azurity Pharmaceuticals, INC. | $24.95 | 2025 | Edarbi |
| Bayer Healthcare Pharmaceuticals INC. | $22.47 | 2021 | |
| Akcea Therapeutics, INC. | $22.00 | 2020 | |
| Irhythm Technologies, INC. | $21.48 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $20.14 | 2023 | Arcalyst |
| Preventice Services, LLC | $19.27 | 2019 | |
| Baxter Healthcare | $12.85 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Yesenosky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.